Identification and Enzymatic Activity Evaluation of a Novel CYP2C9 Allelic Variant Discovered in a Patient

Warfarin is a widely prescribed anticoagulant but the doses required to attain the optimum therapeutic effect exhibit dramatic inter-individual variability. Pharmacogenomics-guided warfarin dosing has been recommended to improve safety and effectiveness. We analyzed the cytochrome P450 2C9 (CYP2C9)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Zhou, Xiao-Yang, Lu, Xiang-Ran, Li, Ying-Hui, Ma, Ya-Qing, Zhao, Shi-Wen, Wang, Fang, Xu, Ren-Ai, Hu, Guo-Xin, Cai, Jian-Ping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905303/
https://ncbi.nlm.nih.gov/pubmed/33643050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.619339
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak